Dr. Raluca Dinu - 09 Apr 2025 Form 4 Insider Report for QT IMAGING HOLDINGS, INC. (QTIH)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Apr 2025, 21:09:05 UTC
Prior SEC filing
25 Mar 2025
Next SEC filing
23 Apr 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dr. Raluca Dinu

Key filing fact

Dr. Raluca Dinu filed Form 4 for QT IMAGING HOLDINGS, INC. (QTIH) on 10 Apr 2025.

Key facts

  • This page summarizes Dr. Raluca Dinu's Form 4 filing for QT IMAGING HOLDINGS, INC. (QTIH).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 10 Apr 2025, 21:09.

Change

  • Previous filing in this sequence was filed on 25 Mar 2025.
  • Current net transaction value: +$250,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

QTI transaction

Common Stock

Purchase

Transaction value
$250,000
Shares
+392,465
Change %
+51%
Price
$0.6370
Shares after
1,168,035
Date
09 Apr 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

QTI transaction Derivative

Subscription Warrants (right to buy)

Purchase

Transaction value
$0
Shares
+784,929
Change %
Price
$0.000000
Shares after
784,929
Date
09 Apr 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
784,929
Exercise price
$0.7200
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares and warrants represent 50% of the shares and warrants that were purchased jointly with the Reporting Person's spouse, Dr. Avi S. Katz, who is also a director of the Issuer and is separately reporting the other 50% of such purchased shares and warrants.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .